AUREALIS PHARMA Trademark

Trademark Overview


On Monday, July 25, 2016, a trademark application was filed for AUREALIS PHARMA with the United States Patent and Trademark Office. The USPTO has given the AUREALIS PHARMA trademark a serial number of 87114798. The federal status of this trademark filing is REGISTERED as of Tuesday, January 23, 2018. This trademark is owned by Aurealis Pharma AG. The AUREALIS PHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and veterinary preparations, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; sanitary preparations for medical purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; dietetic food and substances, namely, fermented milk products, drinks and gum, adapted for medical or veterinary use; dietary supplements for humans and animals; health care products, namely, plasters, materials for dressings, ointments, sprays, injections, human therapeutics, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; disinfectants; preparations for destroying vermin; fungicides and herbicides; pharmaceuticals, biosimilars, medicine, drugs, namely, immunomodulators and anticancer agents, antibodies, antibody fragments, checkpoint inhibitors and checkpoint modifiers, vaccines, for human b...
aurealis pharma

General Information


Serial Number87114798
Word MarkAUREALIS PHARMA
Filing DateMonday, July 25, 2016
Status700 - REGISTERED
Status DateTuesday, January 23, 2018
Registration Number5383359
Registration DateTuesday, January 23, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 17, 2017

Trademark Statements


Goods and ServicesPharmaceutical and veterinary preparations, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; sanitary preparations for medical purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; dietetic food and substances, namely, fermented milk products, drinks and gum, adapted for medical or veterinary use; dietary supplements for humans and animals; health care products, namely, plasters, materials for dressings, ointments, sprays, injections, human therapeutics, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; disinfectants; preparations for destroying vermin; fungicides and herbicides; pharmaceuticals, biosimilars, medicine, drugs, namely, immunomodulators and anticancer agents, antibodies, antibody fragments, checkpoint inhibitors and checkpoint modifiers, vaccines, for human beings and animals; prokaryotic organisms, namely, genetically modified bacteria, bacteria producing growth factors, antibodies, immunomodulators, anticancer agents, checkpoint inhibitors and checkpoint modifiers and vaccines; medicines for human purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; medicines for veterinary purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; bacteriological preparations for medical and veterinary use, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; biological preparations for medical purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; biological preparations for veterinary purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; chemical preparations for medical purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; chemical preparations for pharmaceutical purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; chemical preparations for veterinary purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; pharmaceutical and veterinary preparations and substances in particular for the treatment of cancer, inflammatory diseases, immune system related diseases, specifically autoimmune disorders, and other conditions which can be treated or ameliorated by antibodies or antibody fragments binding to, activating or blocking of a target antigen or ameliorated by immunomodulating factors, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer
Disclaimer with Predetermined Text"PHARMA"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 28, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAurealis Pharma AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBasel 4058
CH

Party NameAurealis Pharma AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBasel 4058
CH

Party NameAurealis Pharma AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBasel 4058
CH

Trademark Events


Event DateEvent Description
Monday, January 23, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, January 23, 2018REGISTERED-PRINCIPAL REGISTER
Friday, December 15, 2017NOTICE OF ALLOWANCE CANCELLED
Tuesday, December 12, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 17, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 17, 2017PUBLISHED FOR OPPOSITION
Wednesday, September 27, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, September 11, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 16, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 16, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 10, 2017ASSIGNED TO LIE
Friday, July 14, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, May 12, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, May 12, 2017LETTER OF SUSPENSION E-MAILED
Friday, May 12, 2017SUSPENSION LETTER WRITTEN
Thursday, May 11, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 9, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 9, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 10, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 10, 2016NON-FINAL ACTION E-MAILED
Thursday, November 10, 2016NON-FINAL ACTION WRITTEN
Thursday, November 3, 2016ASSIGNED TO EXAMINER
Thursday, July 28, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 28, 2016NEW APPLICATION ENTERED